Your browser doesn't support javascript.
loading
Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab.
Yamaguchi, Ou; Kaira, Kyoichi; Hashimoto, Kosuke; Mouri, Atsuto; Miura, Yu; Shiono, Ayako; Nishihara, Fuyumi; Murayama, Yoshitake; Noda, Shin-Ei; Kato, Shingo; Kobayashi, Kunihiko; Kagamu, Hiroshi.
Affiliation
  • Yamaguchi O; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Kaira K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Hashimoto K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Mouri A; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Miura Y; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Shiono A; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Nishihara F; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Murayama Y; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Noda SE; Department of Radiation Oncology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Kato S; Department of Radiation Oncology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Kobayashi K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
  • Kagamu H; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka-City, Japan.
Thorac Cancer ; 10(4): 992-1000, 2019 04.
Article in En | MEDLINE | ID: mdl-30888716
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Nivolumab / Lung Neoplasms / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Thorac Cancer Year: 2019 Document type: Article Affiliation country: Japan Country of publication: Singapore
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Nivolumab / Lung Neoplasms / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Thorac Cancer Year: 2019 Document type: Article Affiliation country: Japan Country of publication: Singapore